IDEAYA Biosciences promotes Michael White to president of R&D
IDYA•IDEAYA Biosciences promoted Michael White to president of research and development, effective Sept. 28, 2026.
1. Leadership promotion
White had served as IDEAYA’s chief scientific officer since 2021. Before joining the company, he was Pfizer’s chief scientific officer and head of tumor biology, leading oncology small-molecule pipeline development; earlier, he was a professor at UT Southwestern and founding director of its Cancer Intervention and Prevention Discovery Program.
